[Investigation of the prevalence of swine torque teno virus in Austria]. / Untersuchung zur Verbreitung des Torque Teno-virus beim Schwein in Osterreich.

In the present retrospective study, serum samples from a total of 253 pigs of different age groups from 83 farms collected in the year 2008 were included.The sera were analysed for the presence of torque teno virus (TTV) genogroups 1 and 2. Furthermore, the correlation between TTV and PCV-2 was investigated. 62.1% of the pigs were positive for TTV1 and/or TTV2 by PCR. 21.7% of the samples were positive for TTV1 and TTV2, 16.2% only for TTV1 and 23.3% only for TTV2. In 80.7% of the investigated farms at least one animal was TTV positive. In the growing and fattening period significantly more pigs were positive for TTV than in other age classes. A positive association was found between TTV1 and IgM against PCV-2, between TTV2 and PCV-2 results by in situ hybridisation (ISH) as well as TTV1 and TTV2 and PCV-2 results by qPCR. A significant correlation could also be seen between the diagnosis,porcine respiratory disease complex (PRDC)" and the detection of TTV, whereas there was none to the diagnosis "porcine dermatitis and nephropathy syndrome (PDNS)". In the present study, TTV was detected in Austria for the first time.

Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation.

In recent years, clusters of Pneumocystis jirovecii (formerly Pneumocystis carinii) pneumonia (PCP) among immunocompromised individuals have been reported. Mostly, the source of infections was suspected to be within the clinical settings when transplant recipients and PCP patients shared hospital facilities. We report on a cluster of 16 renal transplant recipients positive for P. jirovecii. None of them received anti-Pneumocystis prophylaxis prior to P. jirovecii detection. Epidemiological studies revealed that 15 of them had received kidney transplants at a German university hospital and attended the same inpatient and outpatient clinic from January through September 2006. Multilocus sequence typing (MLST) was performed on the following genes: ITS1, beta-tub, 26S, and mt26S. P. jirovecii DNA was available from 14 patients and showed identical MLST types among these renal transplant recipients. Surprisingly, one patient who was treated at a different nephrological center and reported no personal contact with patients from the renal transplantation cluster harbored an identical P. jirovecii MLST type. Three HIV-positive patients and one bone-marrow-transplanted hematologic malignancy patient--treated at different medical centers--were used as controls, and different MLST types were revealed. Interestingly, in three of the four previously described regions, new alleles were detected, and one new polymorphism was observed in the mt26S region. The epidemiological data and the genotyping results strongly suggest a nosocomial patient-to-patient transmission of P. jirovecii as the predominant transmission route. Therefore, strict segregation and isolation of P. jirovecii-positive/suspected patients in clinical settings seems warranted.